Windtree Therapeutics enters $60 million BNB crypto treasury deal

Published 16/07/2025, 14:26

Windtree Therapeutics, Inc. (WINT) announced it has entered into a $60 million securities purchase agreement led by Build and Build Corp, with potential for up to $140 million in additional future subscriptions, totaling up to $200 million in gross proceeds.

The proceeds, expected to include cash, shares of Osprey BNB Chain Trust and BNB tokens, will be used to launch a BNB crypto treasury strategy and purchase BNB tokens. The transaction requires shareholder approval and satisfaction of other closing conditions.

According to the press release, the deal would make Windtree the first NASDAQ-listed company offering direct exposure to the BNB token. BNB is associated with the Binance ecosystem and represents the fifth-largest blockchain by market capitalization at over $95 billion.

"We are thrilled to propose a groundbreaking BNB strategy to the U.S. market," said Patrick Horsman, CFA, Director of Build & Build Corp. "This innovative solution will offer investors targeted exposure to Binance and BNB, addressing what we believe to be a critical gap in the U.S. investment landscape."

BNB maintains average daily trading volumes of over $2 billion and serves as the native token for the Binance Smart Chain, which supports decentralized finance applications and transactions.

"Today marks a pivotal moment for Windtree," said Jed Latkin, Chief Executive Officer of Windtree. "This transaction secures up to $200 million from institutional investors, offering our shareholders a unique opportunity to gain exposure to a BNB-focused crypto treasury strategy."

Build and Build Corp was established by Patrick Horsman, Joshua Kruger, and Johnathan Pasch, who collectively bring over 43 years of experience in hedge funds and digital asset management. The company is backed by investors including Off The Chain Capital, Kraken, Galaxy, and Silvermine.

Windtree Therapeutics describes itself as a diversified company with divisions including a cryptocurrency treasury strategy and therapeutic pipelines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.